Controlled trial of aspirin in cerebral ischemia (AITIA study).
作者信息
Fields W S, Lemak N A, Frankowski R F, Hardy R J
出版信息
Thromb Haemost. 1979 Feb 28;41(1):135-41.
PMID:384582
Abstract
摘要
相似文献
1
Controlled trial of aspirin in cerebral ischemia (AITIA study).
Thromb Haemost. 1979 Feb 28;41(1):135-41.
2
Controlled trial of aspirin in cerebral ischemia.阿司匹林治疗脑缺血的对照试验。
Circulation. 1980 Dec;62(6 Pt 2):V90-6.
3
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Circulation. 1980 Dec;62(6 Pt 2):V88-9.
4
The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
Agents Actions Suppl. 1984;15:279-82.
5
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.缺血性卒中的抗血小板治疗：临床试验中的变异性及其对选择合适治疗方法的影响。
J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19.
6
Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
Ann Neurol. 1979 Jun;5(6):599-601. doi: 10.1002/ana.410050626.
7
Controversy in the interpretation of clinical trials.临床试验解读中的争议。
Ann Neurol. 1979 Jun;5(6):601-2. doi: 10.1002/ana.410050627.
8
9
Aspirin and the prevention of stroke after transient ischaemic attack.
Monogr Atheroscler. 1986;14:203-6.
10
MATCH results: implications for the internist.MATCH研究结果：对内科医生的启示
Am J Med. 2006 Jun;119(6):526.e1-7. doi: 10.1016/j.amjmed.2005.10.047.
引用本文的文献
1
European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.欧洲卒中组织（ESO）关于缺血性卒中或短暂性脑缺血发作后长期二级预防的药物干预指南。
Eur Stroke J. 2022 Sep;7(3):I-II. doi: 10.1177/23969873221100032. Epub 2022 Jun 3.
Zotero 插件